The most prevalent are constitutive activation of NOTCH1 signaling, observed in up to 60% of T-ALL patients [13], and loss of the CDKN2A/p16INK4a (chromosome 9p21) locus [14], occurring in up to 70% of cases. Here, NOTCH1 is linked to acute lymphoblastic leukemia.